Tandem Diabetes Care (TNDM) EPS (Diluted) Growth (1y) (2019 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 13.96% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | 60.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.67% |
| Mar 31, 2026 | 84.82% |
| Dec 31, 2025 | -168.15% |
| Sep 30, 2025 | 11.91% |
| Jun 30, 2025 | -64.68% |
| Mar 31, 2025 | -200.69% |
| Dec 31, 2024 | 102.57% |
| Sep 30, 2024 | 29.91% |
| Jun 30, 2024 | 14.00% |
| Mar 31, 2024 | 65.92% |
| Dec 31, 2023 | -86.64% |
| Sep 30, 2023 | 33.60% |
| Jun 30, 2023 | -134.08% |
| Mar 31, 2023 | -733.27% |
| Dec 31, 2022 | -247.74% |
| Sep 30, 2022 | -959.20% |
| Jun 30, 2022 | -486.99% |
| Mar 31, 2022 | -183.00% |
| Dec 31, 2021 | -39.99% |
| Sep 30, 2021 | 157.84% |